QLGN - Qualigen Therapeutics EPS beats by $0.01 beats on revenue
Qualigen Therapeutics (QLGN): Q1 GAAP EPS of -$0.13 beats by $0.01.Revenue of $1.9M (+111.1% Y/Y) beats by $0.7M.As of March 31, 2021, Qualigen Therapeutics had $21.9 million of cash and cash equivalents.Press Release
For further details see:
Qualigen Therapeutics EPS beats by $0.01, beats on revenue